Pathophysiological roles of myristoylated alanine-rich C-kinase substrate (MARCKS) in hematological malignancies.

Iyer, Deepak Narayanan; Faruq, Omar; Zhang, Lun; Rastgoo, Nasrin; Liu, Aijun; Chang, Hong

Iyer, Deepak Narayanan; Faruq, Omar; Zhang, Lun; Rastgoo, Nasrin; Liu, Aijun; Chang, Hong.

Afiliación

Iyer DN; Laboratory medicine program, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada.
Faruq O; Laboratory medicine program, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada.
Zhang L; Laboratory medicine program, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada.
Rastgoo N; Laboratory medicine program, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada.
Liu A; Department of Hematology, Beijing Chaoyang Hospital, Capital University, Beijing, China. aijun.liu72@yahoo.com.
Chang H; Laboratory medicine program, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada. hong.chang@uhn.ca.

Biomark Res ; 9(1): 34, 2021 May 06.

Article en En | MEDLINE | ID: mdl-33958003

Palabras clave

Drug resistance; Hematological cancers; MARCKS; Targeted therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biomark Res Año: 2021 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google